Cargando…
Nitroreductase‐Mediated Release of Inhibitors of Lysine‐Specific Demethylase 1 (LSD1) from Prodrugs in Transfected Acute Myeloid Leukaemia Cells
Lysine‐specific demethylase 1 (LSD1) has evolved as a promising therapeutic target for cancer treatment, especially in acute myeloid leukaemia (AML). To approach the challenge of site‐specific LSD1 inhibition, we developed an enzyme‐prodrug system with the bacterial nitroreductase NfsB (NTR) that wa...
Autores principales: | Herrlinger, Eva‐Maria, Hau, Mirjam, Redhaber, Desiree Melanie, Greve, Gabriele, Willmann, Dominica, Steimle, Simon, Müller, Michael, Lübbert, Michael, Miething, Christoph Cornelius, Schüle, Roland, Jung, Manfred |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7497180/ https://www.ncbi.nlm.nih.gov/pubmed/32227662 http://dx.doi.org/10.1002/cbic.202000138 |
Ejemplares similares
-
Lsd1 regulates skeletal muscle regeneration and directs the fate of satellite cells
por: Tosic, Milica, et al.
Publicado: (2018) -
Expanding the Role of the Histone Lysine-Specific Demethylase LSD1 in Cancer
por: Majello, Barbara, et al.
Publicado: (2019) -
Roles of lysine-specific demethylase 1 (LSD1) in homeostasis and diseases
por: Kim, Dongha, et al.
Publicado: (2021) -
The Catalytic-Dependent and -Independent Roles of Lsd1 and Lsd2 Lysine Demethylases in Heterochromatin Formation in Schizosaccharomyces pombe
por: Marayati, Bahjat F., et al.
Publicado: (2020) -
Lysine-specific histone demethylase 1A (LSD1) in cervical cancer
por: Beilner, Daniel, et al.
Publicado: (2020)